Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$14 Mln
P/E Ratio
--
P/B Ratio
7.11
Industry P/E
81.98
Debt to Equity
0
ROE
-6.87 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-8.59
CFO
$-334.07 Mln
EBITDA
$-320.76 Mln
Net Profit
$-435.07 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Vapotherm (VAPO)
| 117.00 | 0.93 | 1.88 | -33.23 | -78.80 | -51.20 | -- |
|
BSE Sensex*
| 2.10 | 3.88 | 4.41 | 8.35 | 11.78 | 20.18 | 11.16 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|
|
Vapotherm (VAPO)
| -95.37 | -86.96 | -22.90 | 120.89 | -39.05 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and... internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire. Read more
CEO, President & Director
Mr. Joseph F. Army CPA
Senior VP, CFO & Treasurer
Mr. John Landry
Headquarters
Exeter, NH
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Vapotherm Inc (VAPO) stood at $ 215 Mln as on 30-Jun-24
The share price of Vapotherm Inc (VAPO) is $2.17 (NYSE) as of 19-Sep-2024 15:20 EDT. Vapotherm Inc (VAPO) has given a return of -78.8% in the last 3 years.
Vapotherm Inc (VAPO) has a market capitalisation of $ 14 Mln as on 19-Sep-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Vapotherm Inc (VAPO) is 7.11 times as on 19-Sep-2024, a 118% premium to its peers’ median range of 3.26 times.
Since, TTM earnings of Vapotherm Inc (VAPO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Vapotherm Inc (VAPO) and enter the required number of quantities and click on buy to purchase the shares of Vapotherm Inc (VAPO).
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
The CEO & director of Mr. Joseph F. Army CPA. is Vapotherm Inc (VAPO), and CFO & Sr. VP is Mr. John Landry.
There is no promoter pledging in Vapotherm Inc (VAPO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Vapotherm Inc. (VAPO) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
-38.87
|
|
Net Margin(%)
|
-76.74
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Vapotherm Inc (VAPO) was $0 Mln.
$-0.01
(
